Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,509 | 1,364 | 1,637 | 70 | 579 |
| Marketable Securities | N/A | N/A | 579 | 5,090 | 8,751 |
| Other current assets | 0 | 475 | 578 | 1,153 | 0 |
| TOTAL | $1,851 | $1,839 | $2,793 | $6,313 | $9,816 |
| Non-Current Assets | |||||
| PPE Net | 136 | 169 | 196 | 232 | 276 |
| Other Non-Current Assets | 381 | 382 | 384 | 399 | 424 |
| TOTAL | $518 | $551 | $579 | $630 | $700 |
| Total Assets | $2,369 | $2,390 | $3,373 | $6,943 | $10,516 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,674 | 2,513 | 1,982 | 2,127 | 2,289 |
| Accrued Expenses | 31 | 30 | 29 | 26 | 61 |
| TOTAL | $18,705 | $4,543 | $2,011 | $2,152 | $2,350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 236 | 246 | 254 | 261 | 274 |
| TOTAL | $236 | $246 | $254 | $261 | $274 |
| Total Liabilities | $18,941 | $4,789 | $2,264 | $2,414 | $2,624 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 3 | 3 | 3 |
| Common Shares | 166 | 165 | 165 | 165 | 165 |
| Retained earnings | -143,504 | -129,050 | -125,037 | -121,113 | -117,148 |
| Other shareholders' equity | 0 | 0 | -1 | -8 | -12 |
| TOTAL | $-16,572 | $-2,400 | $1,109 | $4,529 | $7,891 |
| Total Liabilities And Equity | $2,369 | $2,390 | $3,373 | $6,943 | $10,516 |